Reiss W - Search Results

1

Low immunogenicity of tocilizumab in patients with rheumatoid arthritis.

Burmester GR, Choy E, Kivitz A, Ogata A, Bao M, Nomura A, Lacey S, Pei J, Reiss W, Pethoe-Schramm A, Mallalieu NL, Wallace T, Michalska M, Birnboeck H, Stubenrauch K, Genovese MC. Burmester GR, et al. Among authors: reiss w. Ann Rheum Dis. 2017 Jun;76(6):1078-1085. doi: 10.1136/annrheumdis-2016-210297. Epub 2016 Dec 22. Ann Rheum Dis. 2017. PMID: 28007755 Free article.

2

Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients.

Genovese MC, Breedveld FC, Emery P, Cohen S, Keystone E, Matteson EL, Baptiste Y, Chai A, Burke L, Reiss W, Sweetser M, Shaw TM. Genovese MC, et al. Among authors: reiss w. Ann Rheum Dis. 2009 Dec;68(12):1894-7. doi: 10.1136/ard.2008.101675. Epub 2009 Jan 20. Ann Rheum Dis. 2009. PMID: 19155233 Free article.

3

Sustained Response Following Discontinuation of Methotrexate in Patients With Rheumatoid Arthritis Treated With Subcutaneous Tocilizumab: Results From a Randomized, Controlled Trial.

Kremer JM, Rigby W, Singer NG, Birchwood C, Gill D, Reiss W, Pei J, Michalska M. Kremer JM, et al. Among authors: reiss w. Arthritis Rheumatol. 2018 Aug;70(8):1200-1208. doi: 10.1002/art.40493. Epub 2018 Jun 14. Arthritis Rheumatol. 2018. PMID: 29575803 Clinical Trial.

4

Comment on 'Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab'.

Pethoe-Schramm A, Devenport J, Reiss W. Pethoe-Schramm A, et al. Among authors: reiss w. Ann Rheum Dis. 2022 Aug;81(8):e136. doi: 10.1136/annrheumdis-2020-218365. Epub 2020 Jul 31. Ann Rheum Dis. 2022. PMID: 32737114 No abstract available.

5

Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.

Khawaja MN, Bergman MJ, Yourish J, Pei J, Reiss W, Keystone E. Khawaja MN, et al. Among authors: reiss w. Arthritis Care Res (Hoboken). 2017 May;69(5):609-615. doi: 10.1002/acr.23008. Epub 2017 Apr 7. Arthritis Care Res (Hoboken). 2017. PMID: 27564431 Clinical Trial.

6

Magnetic Resonance Imaging (MRI) Results Following Discontinuation of Methotrexate in Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: The COMP-ACT MRI Substudy.

Peterfy C, Kremer J, Rigby W, Singer N, Birchwood C, Gill D, Reiss W, Pei J, Michalska M. Peterfy C, et al. Among authors: reiss w. J Rheumatol. 2020 Mar;47(3):325-332. doi: 10.3899/jrheum.180953. Epub 2019 Jun 1. J Rheumatol. 2020. PMID: 31154414 Free article. Clinical Trial.

7

Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis.

Reiss WG, Devenport JN, Low JM, Wu G, Sasso EH. Reiss WG, et al. Rheumatol Int. 2016 Feb;36(2):295-300. doi: 10.1007/s00296-015-3285-2. Epub 2015 May 31. Rheumatol Int. 2016. PMID: 26026604 Free PMC article. Clinical Trial.

8

Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies.

Haraoui B, Casado G, Czirják L, Taylor A, Bernasconi C, Reiss W, Caporali R. Haraoui B, et al. Among authors: reiss w. Clin Exp Rheumatol. 2017 Nov-Dec;35(6):899-906. Epub 2017 Apr 28. Clin Exp Rheumatol. 2017. PMID: 28516886

9

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.

Salama C, Han J, Yau L, Reiss WG, Kramer B, Neidhart JD, Criner GJ, Kaplan-Lewis E, Baden R, Pandit L, Cameron ML, Garcia-Diaz J, Chávez V, Mekebeb-Reuter M, Lima de Menezes F, Shah R, González-Lara MF, Assman B, Freedman J, Mohan SV. Salama C, et al. Among authors: reiss wg. N Engl J Med. 2021 Jan 7;384(1):20-30. doi: 10.1056/NEJMoa2030340. Epub 2020 Dec 17. N Engl J Med. 2021. PMID: 33332779 Free PMC article. Clinical Trial.

10

Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis.

Best JH, Abbass I, Tominna L, Reiss W. Best JH, et al. Among authors: reiss w. Am Health Drug Benefits. 2020 May;13(2):72-73. Am Health Drug Benefits. 2020. PMID: 32724501 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page